GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Other Current Receivables

ME Therapeutics Holding (XCNQ:METX) Other Current Receivables : C$0.01 Mil (As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Other Current Receivables?

ME Therapeutics Holding's Other Current Receivables for the quarter that ended in Feb. 2024 was C$0.01 Mil.

ME Therapeutics Holding's quarterly Other Current Receivables increased from Aug. 2023 (C$0.01 Mil) to Nov. 2023 (C$0.03 Mil) but then stayed the same from Nov. 2023 (C$0.03 Mil) to Feb. 2024 (C$0.01 Mil).

ME Therapeutics Holding's annual Other Current Receivables increased from . 20 (C$0.00 Mil) to Aug. 2022 (C$0.02 Mil) but then declined from Aug. 2022 (C$0.02 Mil) to Aug. 2023 (C$0.01 Mil).


ME Therapeutics Holding Other Current Receivables Historical Data

The historical data trend for ME Therapeutics Holding's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Other Current Receivables Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Other Current Receivables
0.02 0.01

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Other Current Receivables Get a 7-Day Free Trial 0.01 0.01 0.01 0.03 0.01

ME Therapeutics Holding Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


ME Therapeutics Holding Other Current Receivables Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


ME Therapeutics Holding (XCNQ:METX) Business Description

Comparable Companies
Traded in Other Exchanges
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines